X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (167) 167
life sciences & biomedicine (163) 163
humans (149) 149
male (106) 106
middle aged (95) 95
female (94) 94
adult (81) 81
cardiovascular system & cardiology (70) 70
cardiac & cardiovascular systems (62) 62
risk factors (60) 60
hypercholesterolemia (53) 53
familial hypercholesterolemia (47) 47
cardiovascular (45) 45
aged (44) 44
peripheral vascular disease (36) 36
cholesterol (32) 32
genetic aspects (32) 32
cardiovascular disease (31) 31
mutation (31) 31
atherosclerosis (29) 29
hyperlipoproteinemia type ii - genetics (29) 29
cholesterol, ldl - blood (28) 28
spain (27) 27
abridged index medicus (26) 26
lipids (26) 26
low density lipoproteins (25) 25
spain - epidemiology (24) 24
research (23) 23
nutrition & dietetics (21) 21
receptors, ldl - genetics (20) 20
biochemistry & molecular biology (19) 19
body mass index (19) 19
obesity (19) 19
pharmacology & pharmacy (19) 19
young adult (19) 19
low density lipoprotein (18) 18
prevalence (18) 18
triglycerides - blood (18) 18
diabetes (17) 17
hyperlipoproteinemia type ii - diagnosis (17) 17
statins (17) 17
adolescent (16) 16
cardiovascular diseases - prevention & control (16) 16
general & internal medicine (16) 16
case-control studies (15) 15
heterozygote (15) 15
medicine, general & internal (15) 15
analysis (14) 14
hyperlipoproteinemia type ii - blood (14) 14
hypolipidemic agents - therapeutic use (14) 14
lipoproteins (14) 14
cardiovascular diseases (13) 13
genotype (13) 13
internal medicine (13) 13
registries (13) 13
risk assessment (13) 13
apolipoproteins (12) 12
cardiovascular risk (12) 12
care and treatment (12) 12
cholesterol, hdl - blood (12) 12
diagnosis (12) 12
endocrinology & metabolism (12) 12
hyperlipoproteinemia type ii - complications (12) 12
hyperlipoproteinemia type ii - drug therapy (12) 12
phenotype (12) 12
treatment outcome (12) 12
apolipoproteins e - genetics (11) 11
cardiovascular diseases - epidemiology (11) 11
cardiovascular diseases - etiology (11) 11
coronary heart disease (11) 11
double-blind method (11) 11
genetic predisposition to disease (11) 11
genetics & heredity (11) 11
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (11) 11
medical research (11) 11
prospective studies (11) 11
triglycerides (11) 11
cholesterol - blood (10) 10
cross-sectional studies (10) 10
hyperlipoproteinemia type ii - epidemiology (10) 10
insulin resistance (10) 10
medicine, experimental (10) 10
metabolic syndrome (10) 10
physiological aspects (10) 10
polymorphism, single nucleotide (10) 10
ultrasonography (10) 10
atherosclerosis - epidemiology (9) 9
clinical trials (9) 9
drug therapy (9) 9
follow-up studies (9) 9
gene expression (9) 9
genetic variation (9) 9
genetics (9) 9
hypertension (9) 9
hypertriglyceridemia (9) 9
prognosis (9) 9
age factors (8) 8
aged, 80 and over (8) 8
anticholesteremic agents - therapeutic use (8) 8
apolipoproteins b - genetics (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9965, pp. 331 - 340
Journal Article
Revista española de cardiologia, ISSN 0300-8932, 06/2017, Volume 70, Issue 6, pp. 423 - 424
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 08/2019, Volume 381, Issue 6, pp. 531 - 542
This phase 3 trial showed that treatment with volanesorsen, an antisense oligonucleotide drug complementary to mRNA encoding apolipoprotein C-III, resulted in... 
Double-Blind Method | Oligonucleotides/administration & dosage | Thrombocytopenia/chemically induced | Humans | Middle Aged | RNA, Messenger/antagonists & inhibitors | Hyperlipoproteinemia Type I/blood | Male | Injections, Subcutaneous/adverse effects | Young Adult | Platelet Count | Analysis of Variance | Triglycerides/blood | Adult | Female | Aged | Apolipoprotein C-III/antagonists & inhibitors | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Apolipoprotein C-III - antagonists & inhibitors | Oligonucleotides - therapeutic use | Hyperlipoproteinemia Type I - blood | Apolipoprotein C-III - blood | Oligonucleotides - adverse effects | Apolipoprotein C-III - genetics | Injections, Subcutaneous - adverse effects | Thrombocytopenia - chemically induced | RNA, Messenger - antagonists & inhibitors | Triglycerides - blood | Hyperlipoproteinemia Type I - drug therapy | Oligonucleotides - administration & dosage | Usage | Safety and security measures | Genetic disorders | Chylomicrons | Drug therapy | Health aspects | Antilipemic agents | Thrombocytopenia | Fasting | Statistical analysis | Laboratories | Pancreatitis | Clinical trials | Antisense therapy | mRNA | Lipoprotein lipase | Injection | Lipase | Apolipoproteins | Fatty acids | Lipoproteins | Apolipoprotein C-III | Mutation | Platelets | Drug dosages | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Life Sciences
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2016, Volume 67, Issue 11, pp. 1263 - 1274
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 119, Issue 5, pp. 742 - 748
Journal Article
European heart journal, ISSN 0195-668X, 2015, Volume 36, Issue 43, pp. 2996 - 3003
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2008, Volume 52, Issue 19, pp. 1546 - 1553
Journal Article